PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of bmcneulBioMed Centralsearchsubmit a manuscriptregisterthis articleBMC Neurology
 
BMC Neurol. 2007; 7: 39.
Published online Nov 8, 2007. doi:  10.1186/1471-2377-7-39
PMCID: PMC2222229
Protocol for the Locomotor Experience Applied Post-stroke (LEAPS) trial: a randomized controlled trial
Pamela W Duncan,corresponding author1,2,3 Katherine J Sullivan,4 Andrea L Behrman,5,6 Stanley P Azen,7 Samuel S Wu,8 Stephen E Nadeau,6,9 Bruce H Dobkin,10 Dorian K Rose,11 Julie K Tilson,4 and The LEAPS Investigative Team
1Division of Doctor of Physical Therapy, Department of Community and Family Medicine, Duke University, Durham, North Carolina, USA
2Center for Clinical Health Policy Research, Duke University, Durham, North Carolina, USA
3Center for Aging, Duke University, Durham, North Carolina, USA
4Department of Biokinesiology and Physical Therapy, University of Southern California, Los Angeles, California, USA
5Department of Physical Therapy, Brooks Center for Rehabilitation Studies, University of Florida, Gainesville, Florida, USA
6Department of Veteran Affairs Brain Rehabilitation Research Center, Gainesville, Florida, USA
7Biostatistics Division, Department of Preventive Medicine, University of Southern California, Los Angeles, California, USA
8Department of Epidemiology and Health Policy Research, University of Florida, Florida, USA
9Geriatric Research, Education and Clinical Center, Malcom Randall VA Medical Center, Gainesville, Florida, USA
10Department of Neurology, University of California, Los Angeles, California, USA
11Department of Aging and Geriatric Research, University of Florida, Gainesville, Florida, USA
corresponding authorCorresponding author.
Pamela W Duncan: Pamela.Duncan/at/Duke.edu; Katherine J Sullivan: kasulliv/at/usc.edu; Andrea L Behrman: abehrman/at/phhp.ufl.edu; Stanley P Azen: sazen/at/usc.edu; Samuel S Wu: samwu/at/biostat.ufl.edu; Stephen E Nadeau: snadeau/at/ufl.edu; Bruce H Dobkin: bdobkin/at/mednet.ucla.edu; Dorian K Rose: drose/at/aging.ufl.edu; Julie K Tilson: tilson/at/usc.edu
Received June 25, 2007; Accepted November 8, 2007.
Abstract
Background
Locomotor training using body weight support and a treadmill as a therapeutic modality for rehabilitation of walking post-stroke is being rapidly adopted into clinical practice. There is an urgent need for a well-designed trial to determine the effectiveness of this intervention.
The objective of the Locomotor Experience Applied Post-Stroke (LEAPS) trial is to determine if there is a difference in the proportion of participants who recover walking ability at one year post-stroke when randomized to a specialized locomotor training program (LTP), conducted at 2- or 6-months post-stroke, or those randomized to a home based non-specific, low intensity exercise intervention (HEP) provided 2 months post-stroke. We will determine if the timing of LTP delivery affects gait speed at 1 year and whether initial impairment severity interacts with the timing of LTP. The effect of number of treatment sessions will be determined by changes in gait speed taken pre-treatment and post-12, -24, and -36 sessions.
Methods/Design
We will recruit 400 adults with moderate or severe walking limitations within 30 days of stroke onset. At two months post stroke, participants are stratified by locomotor impairment severity as determined by overground walking speed and randomly assigned to one of three groups: (a) LTP-Early; (b) LTP-Late or (c) Home Exercise Program -Early. The LTP program includes body weight support on a treadmill and overground training. The LTP and HEP interventions are delivered for 36 sessions over 12 weeks.
Primary outcome measure include successful walking recovery defined as the achievement of a 0.4 m/s gait speed or greater by persons with initial severe gait impairment or the achievement of a 0.8 m/s gait speed or greater by persons with initial moderate gait impairment.
LEAPS is powered to detect a 20% difference in the proportion of participants achieving successful locomotor recovery between the LTP groups and the HEP group, and a 0.1 m/s mean difference in gait speed change between the two LTP groups.
Discussion
The goal of this single-blinded, phase III randomized clinical trial is to provide evidence to guide post-stroke walking recovery programs.
Trial registration
NCT00243919.
Articles from BMC Neurology are provided here courtesy of
BioMed Central